id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0496-0004,FDA,FDA-2006-N-0496,Supporting Statement for Orphan Drug Products,Supporting & Related Material,Statement (Supporting and Related Material),2007-08-29T04:00:00Z,2007,8,,,2025-07-01T23:44:13Z,,0,0,090000648046383e
FDA-2006-N-0496-0003,FDA,FDA-2006-N-0496,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Orphan Drugs,Notice,Notice of Approval,2007-08-29T04:00:00Z,2007,8,2007-08-29T04:00:00Z,,2025-07-01T23:41:17Z,E7-17094,0,0,090000648046383c
FDA-2006-N-0496-0002,FDA,FDA-2006-N-0496,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs,Notice,General Notice,2007-05-29T04:00:00Z,2007,5,2007-05-29T04:00:00Z,2007-06-29T03:59:59Z,2025-07-01T23:34:46Z,E7-10271,0,0,090000648046383b